Connor, Clark & Lunn Investment Management (CC&L)’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-45,648
| Closed | -$11.2M | – | 1487 |
|
|
2022
Q3 | $11.2M | Buy |
45,648
+26,711
| +141% | +$6.56M | 0.07% | 187 |
|
|
2022
Q2 | $4.69M | Buy |
+18,937
| New | +$4.69M | 0.03% | 323 |
|
|
2021
Q4 | – | Sell |
-4,263
| Closed | -$1.39M | – | 1248 |
|
|
2021
Q3 | $1.39M | Sell |
4,263
-2,220
| -34% | -$723K | 0.01% | 587 |
|
|
2021
Q2 | $2.02M | Buy |
6,483
+4,925
| +316% | +$1.54M | 0.01% | 539 |
|
|
2021
Q1 | $497K | Buy |
+1,558
| New | +$497K | ﹤0.01% | 796 |
|
|
2019
Q1 | – | Sell |
-6,046
| Closed | -$1.97M | – | 1073 |
|
|
2018
Q4 | $1.97M | Sell |
6,046
-20,779
| -77% | -$6.75M | 0.01% | 422 |
|
|
2018
Q3 | $12.1M | Buy |
26,825
+22,400
| +506% | +$10.1M | 0.07% | 197 |
|
|
2018
Q2 | $1.81M | Buy |
+4,425
| New | +$1.81M | 0.01% | 500 |
|